NPI: 1003861642 · MARION, AR 72364 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/23/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/23/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 17,816 | $221K |
| 2019 | 23,027 | $248K |
| 2020 | 24,738 | $224K |
| 2021 | 19,202 | $127K |
| 2022 | 14,617 | $159K |
| 2023 | 9,016 | $167K |
| 2024 | 6,135 | $120K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 37,430 | 2,795 | $278K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 36,108 | 1,875 | $260K |
| 83970 | 1,724 | 1,452 | $211K | |
| 82728 | 1,444 | 1,283 | $165K | |
| 82108 | 223 | 210 | $67K | |
| 83540 | 1,467 | 1,275 | $62K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 18,075 | 1,432 | $54K |
| A4657 | Syringe, with or without needle, each | 2,635 | 2,094 | $38K |
| 83550 | 797 | 700 | $35K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,052 | 478 | $25K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 124 | 119 | $21K |
| 85041 | 2,014 | 1,740 | $16K | |
| 85048 | 1,990 | 1,719 | $12K | |
| 82746 | 255 | 239 | $7K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 385 | 235 | $4K |
| 83010 | 20 | 12 | $3K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 503 | 200 | $2K |
| G0008 | Administration of influenza virus vaccine | 156 | 128 | $2K |
| 82607 | 118 | 114 | $1K | |
| 90747 | 16 | 13 | $1K | |
| J1756 | Injection, iron sucrose, 1 mg | 7,464 | 1,693 | $1K |
| 90674 | 91 | 72 | $631.72 | |
| 85045 | 460 | 421 | $287.14 |